Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pomdoctor Limited ADR (POM)

Pomdoctor Limited ADR (POM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 40,082
  • Shares Outstanding, K 101,192
  • Annual Sales, $ 5,023 M
  • Annual Income, $ 327,000 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta N/A
  • Price/Sales 0.88
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/06/16
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Services

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/16
See More
  • Average Estimate 0.23
  • Number of Estimates 3
  • High Estimate 0.24
  • Low Estimate 0.22
  • Prior Year 0.24
  • Growth Rate Est. (year over year) -4.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1930 +105.23%
on 02/23/26
0.4400 -9.98%
on 03/09/26
+0.1415 (+55.58%)
since 02/13/26
3-Month
0.1930 +105.23%
on 02/23/26
0.4500 -11.98%
on 12/15/25
-0.0260 (-6.16%)
since 12/12/25

Most Recent Stories

More News
POMDOCTOR LIMITED Announces Strategic Upgrade, Focusing on "AI + Medical-Grade Smart Wearables" to Build a New Ecosystem for Full-Cycle Chronic Disease Management

GUANGZHOU, China , March 13, 2026 /PRNewswire/ -- Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today...

POM : 0.3961 (+3.34%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming Deadlines - POM

NEW YORK , March 12, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against PomDoctor Ltd. ("PomDoctor" or the "Company") (NASDAQ: POM).   Such investors...

POM : 0.3961 (+3.34%)
POM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Pomdoctor To Contact Him Directly To Discuss Their Options

POM : 0.3961 (+3.34%)
POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit

NEW YORK , March 10, 2026 /PRNewswire/ -- 

POM : 0.3961 (+3.34%)
POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit

NEW YORK , March 5, 2026 /PRNewswire/ --

POM : 0.3961 (+3.34%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming Deadlines - POM

NEW YORK , March 5, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against PomDoctor Ltd. ("PomDoctor" or the "Company") (NASDAQ: POM). Such investors are...

POM : 0.3961 (+3.34%)
POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit

NEW YORK , March 2, 2026 /PRNewswire/ --

POM : 0.3961 (+3.34%)
POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Pomdoctor To Contact Him Directly To Discuss Their Options

POM : 0.3961 (+3.34%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming Deadlines - POM

NEW YORK , Feb. 26, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against PomDoctor Ltd. ("PomDoctor" or the "Company") (NASDAQ: POM). Such investors are...

POM : 0.3961 (+3.34%)
POM Investors with Large Losses Should Contact Robbins LLP for Information About the POMDoctor Ltd. Securities Class Action Lawsuit

San Diego , Feb. 24, 2026 /PRNewswire/ -- Robbins LLP  reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ:...

POM : 0.3961 (+3.34%)

Business Summary

POMDOCTOR LIMITED is an online medical services platform for chronic diseases principally in China. The Company's operations primarily include internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals and other healthcare participants. POMDOCTOR...

See More

Key Turning Points

3rd Resistance Point 0.4841
2nd Resistance Point 0.4520
1st Resistance Point 0.4241
Last Price 0.3961
1st Support Level 0.3641
2nd Support Level 0.3320
3rd Support Level 0.3041

See More

52-Week High 6.4300
Fibonacci 61.8% 4.0475
Fibonacci 50% 3.3115
Fibonacci 38.2% 2.5755
Last Price 0.3961
52-Week Low 0.1930

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar